| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.072 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |